Hope for Gliomas: The Ruxolitinib Breakthrough Brain 11 Mins Read1 Gliomas are a complex group of brain and spinal cord tumors that start from glial cells, which are cells that…
Ruxolitinib Safety and Feasibility in NHGGs: Final Toxicity Report Brain 2 Mins Read0 The results of the CRUX study, which focused on the safety and feasibility of the JAK stat inhibitor Ruxolitinib in…
